Castle Biosciences Inc (CSTL) financials · rev $344.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Castle Biosciences Inc (CSTL) rev $344.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $344.2M | $332.1M |
| Cost of Revenue | $71.0M | $60.2M |
| Gross Profit | $273.2M | $271.9M |
| Operating Income | -$42.8M | $8.67M |
| Net Income | -$24.2M | $18.2M |
| EPS (Diluted) | -$0.83 | $0.62 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $578.6M | $531.2M |
| Current Assets | $361.1M | $360.2M |
| Cash & Equivalents | $116.7M | $119.7M |
| Inventory | $10.3M | $8.13M |
| Total Liabilities | $107.7M | $75.4M |
| Current Liabilities | $68.7M | $49.4M |
| Short-term Debt | $417.0K | $278.0K |
| Long-term Debt | $9.64M | $9.74M |
| Total Debt | $10.1M† | $10.0M† |
| Shareholders' Equity | $470.9M | $455.8M |
| Retained Earnings | -$224.3M | -$200.1M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $64.3M | $64.9M |
| CapEx | $36.0M | $28.3M |
| Investing Cash Flow | -$60.4M | -$50.1M |
| Financing Cash Flow | -$6.96M | $6.14M |
| Net Change in Cash | -$2.98M | $20.9M |
| Free Cash Flow | $28.3M | $36.5M |
FAQ
What is CSTL P/E and revenue?
Castle Biosciences Inc (CSTL) rev $344.2M.
What is CSTL revenue?
Castle Biosciences Inc last cached revenue is $344.2M (FY2025).
Is CSTL profitable?
Castle Biosciences Inc last cached net income is -$24.2M (FY2025).
What are CSTL total assets?
Castle Biosciences Inc last cached total assets are $578.6M (FY2025).
What is CSTL free cash flow?
Castle Biosciences Inc last cached free cash flow is $28.3M (FY2025).
Not investment advice. Cached statements, not a live tape.